C. H. Ramsden

478 total citations
20 papers, 222 citations indexed

About

C. H. Ramsden is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Pharmacology. According to data from OpenAlex, C. H. Ramsden has authored 20 papers receiving a total of 222 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Surgery, 5 papers in Pulmonary and Respiratory Medicine and 4 papers in Pharmacology. Recurrent topics in C. H. Ramsden's work include Orthopedic Infections and Treatments (4 papers), Antibiotics Pharmacokinetics and Efficacy (4 papers) and Anesthesia and Pain Management (3 papers). C. H. Ramsden is often cited by papers focused on Orthopedic Infections and Treatments (4 papers), Antibiotics Pharmacokinetics and Efficacy (4 papers) and Anesthesia and Pain Management (3 papers). C. H. Ramsden collaborates with scholars based in United Kingdom. C. H. Ramsden's co-authors include P J Guillou, John R.T. Monson, R C Kester, Eric J. Will, G R Giles, S.P. Conway, J M Littlewood, Ian Harding, Catherine A. Thornton and Susan Bibby and has published in prestigious journals such as British journal of surgery, Transplantation and Journal of Antimicrobial Chemotherapy.

In The Last Decade

C. H. Ramsden

19 papers receiving 204 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C. H. Ramsden United Kingdom 8 70 65 47 40 37 20 222
Martin Claßen Germany 10 46 0.7× 144 2.2× 47 1.0× 28 0.7× 23 0.6× 50 340
Christine Hober France 11 34 0.5× 237 3.6× 32 0.7× 33 0.8× 15 0.4× 28 371
K Abu-Elmagd United States 8 23 0.3× 345 5.3× 24 0.5× 38 0.9× 34 0.9× 8 502
Geoffrey Watkinson United Kingdom 6 19 0.3× 125 1.9× 22 0.5× 103 2.6× 25 0.7× 12 329
R Münch Switzerland 10 11 0.2× 119 1.8× 71 1.5× 49 1.2× 76 2.1× 42 292
I.S. Smith United Kingdom 12 21 0.3× 211 3.2× 45 1.0× 20 0.5× 9 0.2× 21 352
Carolyn Carter United States 5 46 0.7× 49 0.8× 73 1.6× 54 1.4× 8 0.2× 10 324
Woo-Chul Chung South Korea 9 31 0.4× 299 4.6× 54 1.1× 32 0.8× 32 0.9× 23 452
Ida B. Gottschalck Denmark 8 26 0.4× 84 1.3× 65 1.4× 38 0.9× 35 0.9× 13 354
RE Pounder United Kingdom 9 37 0.5× 160 2.5× 49 1.0× 67 1.7× 11 0.3× 32 294

Countries citing papers authored by C. H. Ramsden

Since Specialization
Citations

This map shows the geographic impact of C. H. Ramsden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. H. Ramsden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. H. Ramsden more than expected).

Fields of papers citing papers by C. H. Ramsden

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. H. Ramsden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. H. Ramsden. The network helps show where C. H. Ramsden may publish in the future.

Co-authorship network of co-authors of C. H. Ramsden

This figure shows the co-authorship network connecting the top 25 collaborators of C. H. Ramsden. A scholar is included among the top collaborators of C. H. Ramsden based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. H. Ramsden. C. H. Ramsden is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kester, R C, et al.. (1999). A comparison of teicoplanin versus cephradine plus metronidazole in the prophylaxis of post-operative infection in vascular surgery. Journal of Hospital Infection. 41(3). 233–243. 17 indexed citations
2.
Welsh, Fenella K.S., S M Farmery, C. H. Ramsden, P J Guillou, & John V. Reynolds. (1996). Reversible Impairment in Monocyte Major Histocompatibility Complex Class II Expression in Malnourished Surgical Patients. Journal of Parenteral and Enteral Nutrition. 20(5). 344–348. 11 indexed citations
3.
Jackson, N., H. Jackson, Meredith Bock, C. H. Ramsden, & H.L. Sharma. (1992). Cell-targeted 114Inm and drug (BCNU) combination therapy in a rat acute lymphoblastic leukaemia. Nuclear Medicine Communications. 13(8). 614–619. 1 indexed citations
4.
Jackson, H., et al.. (1990). Experimental investigation into the clearance, targeting and stability of In-114m labelled lymphoid cells.. PubMed. 355. 219–28. 1 indexed citations
5.
Galvin, Kathleen, Catherine A. Thornton, Charles M. Malata, et al.. (1990). A comparison of teicoplanin vs. cephradine and metronidazole in surgical prophylaxis: an interim analysis.. PubMed. 72. 45–53. 4 indexed citations
6.
Ramsden, C. H., et al.. (1989). Teicoplanin: Part 1. An evaluation of the concentrations seen in serum and the subcutaneous fat of the relatively ischaemic lower limb following a single intravenous bolus.. PubMed. 15(1). 21–3. 9 indexed citations
7.
Bibby, Susan, et al.. (1989). Teicoplanin: Part 2. Evaluation of its use in the biliary system.. PubMed. 15(1). 25–7. 7 indexed citations
8.
Johnston, I D A, P J Guillou, T G Brennan, et al.. (1987). Immunorestorative effect of lipid emulsions during total parenteral nutrition. British journal of surgery. 74(2). 153–153. 1 indexed citations
9.
Monson, John R.T., C. H. Ramsden, & P J Guillou. (1986). Decreased interleukin−2 production in patients with gastrointestinal cancer. British journal of surgery. 73(6). 483–486. 71 indexed citations
11.
Ramsden, C. H., et al.. (1984). The penetration of latamoxef disodium (moxalactam) into the subcutaneous fat and skeletal muscle of ischaemic lower limbs with atherosclerotic disease. Journal of Antimicrobial Chemotherapy. 13(4). 377–382. 2 indexed citations
12.
Ramsden, C. H., et al.. (1984). A prospective controlled clinical trial of aminophylline as an adjunctive immunosuppressive agent.. PubMed. 16(5). 1218–20. 3 indexed citations
13.
Whelan, Peter, et al.. (1984). Choosing the Right Intravesical Chemotherapeutic Agent. Results of an In vitro Monolayer Cell Culture Assay. British Journal of Urology. 56(6). 655–657. 3 indexed citations
14.
Guillou, P J, et al.. (1982). CHANGES IN HUMAN NATURAL KILLER ACTIVITY EARLY AND LATE AFTER RENAL TRANSPLANTATION USING CONVENTIONAL IMMUNOSUPPRESSION. Transplantation. 33(4). 414–421. 40 indexed citations
15.
Ramsden, C. H., et al.. (1982). Peroperative cephradine concentrations in the gall bladder wall and bile. Current Medical Research and Opinion. 8(1). 5–8. 5 indexed citations
16.
Ramsden, C. H., et al.. (1981). Cefuroxime levels attained in tissues and wound exudates from severely ischaemic limbs. Journal of Antimicrobial Chemotherapy. 7(2). 163–169. 10 indexed citations
17.
Ramsden, C. H., et al.. (1980). Tissue levels of cephradine in ischaemic limbs following a single intravenous injection. Current Medical Research and Opinion. 6(9). 585–588. 1 indexed citations
18.
Ramsden, C. H., et al.. (1979). The penetrability of cephazolin into the subcutaneous fat and skeletal muscle of ischaemic lower limbs with atherosclerotic disease. Current Medical Research and Opinion. 6(1). 44–49. 4 indexed citations
19.
Ramsden, C. H., et al.. (1979). Evaluation of tissue levels of cefamandole in severely ischaemic lower limbs using two regimens of dosage. Current Medical Research and Opinion. 6(4). 244–248. 1 indexed citations
20.
Ramsden, C. H., et al.. (1978). A study on tissue concentrations of cephradine achieved in patiens with peripheral vascular disease. Current Medical Research and Opinion. 5(6). 427–432. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026